A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Completed · Phase 4

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent

In brief

The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.

Key facts

Study ID

NCT00035568

Run by

Bristol-Myers Squibb

Starts

2002-02-01

Expected to finish

2003-06-01

Last updated by the study team

2011-04-15

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — Little Rock, Arkansas, United States
• Local Institution — Los Angeles, California, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Indianapolis, Indiana, United States
• Local Institution — Brooklyn, New York, United States
• Local Institution — Rochester, New York, United States
• Local Institution — Pittsburgh, Pennsylvania, United States
• Local Institution — Dallas, Texas, United States
• Local Institution — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.